Innovation in Post-Launch Surveillance and Pharmaco-Vigilance (Part Two)
Published on Jun 04, 20132981 Views
These panelists describe struggling to transform their approach to drug safety, while acknowledging the need to regain public trust after troubling episodes involving drug side effects. Névine Zari